Inventiva【0RNK】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

7.62

買値

0.00

売値

0.00

出来高

0.00

0.00 日の範囲 0.00

7.62 52 週間の範囲 7.62

時価総額

397.124M

前日終値

7.62

始値

時刻

(O)

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

287

発行済株式数

52,116,000

配当利回り

PER

-1.10

1 株当たり利益 (EPS)

-2.12

歳入

23.16M

純利益

-110.43M

セクター

Biological Pds,ex Diagnstics

業界

Biological Pds,ex Diagnstics

ウェブサイト

www.inventivapharma.com

本社

Daix, Fra

設立

Inventiva Sa is listed in the Biological Pds,ex Diagnstics sector of the ロンドン証券取引所 with ticker 0RNK. The last closing price for Inventiva was 7.62 €. Over the last year, Inventiva shares have traded in a share price range of 7.62 € to 7.62 €.

Inventiva currently has 52,116,000 shares in issue. The market capitalisation of Inventiva is 397.12 € million. Inventiva has a price to earnings ratio (PE ratio) of -1.10.

Inventiva announces the publication of the results from the investigator-initiated proof-of-concept clinical trial evaluating lanifibranor in patients with T2D and MASLD in the Journal of Hepatology

Inventiva announces the publication of the results from the investigator-initiated proof-of-concept clinical trial evaluating lanifibranor in patients with T2D and MASLD in the Journal of...

Inventiva annonce la publication dans la revue « Journal of Hepatology » des résultats de l’étude clinique de preuve de concept initiée par un investigateur évaluant lanifibranor chez des patients atteints de DT2 et MASLD

Inventiva annonce la publication dans la revue « Journal of Hepatology » des résultats de l’étude clinique de preuve de concept initiée par un investigateur évaluant lanifibranor chez des patients...

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux Daix (France), New York City (New York, United States), January 24, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA...

Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux

Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux Daix (France), New York City (New York, Etats-Unis), le 24 janvier 2025 – Inventiva (Euronext Paris...

Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025

Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025 Daix (France), New York City (New York...

Résultats de LEGEND évaluant la combinaison de lanifibranor avec empagliflozine dans la MASH ont été sélectionnés pour présentation orale au EASL SLD Summit 2025

Résultats de LEGEND évaluant la combinaison de lanifibranor avec empagliflozine dans la MASH ont été sélectionnés pour présentation orale au EASL SLD Summit 2025 Daix (France), New York City (New...

Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference

Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference Daix (France), New York City (New York, United States), December 17, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA...

Inventiva annonce sa participation à la « 43rd Annual J.P. Morgan Healthcare Conference »

Inventiva annonce sa participation à la « 43rd Annual J.P. Morgan Healthcare Conference » Daix (France), New York City (New York, Etats Unis), le 17 décembre 2024 – Inventiva (Euronext Paris and...

Inventiva secures €21.4 million and completes the first tranche of the previously announced multi-tranche financing of up to €348 million

Inventiva secures €21.4 million and completes the first tranche of the previously announced multi-tranche financing of up to €348 million Inventiva secures €21.4 million leading to completion of...

Inventiva obtient 21,4 millions d'euros complétant la première tranche du financement multi-tranches annoncé précédemment d'un montant maximum de 348 millions d'euros

Inventiva obtient 21,4 millions d'euros complétant la première tranche du financement multi-tranches annoncé précédemment d'un montant maximum de 348 millions d'euros Inventiva lève...

期間 †	始値	高値	安値	平均出来高	VWAP
1	7.62	7.62	7.62	115	7.62	DE
4	7.62	7.62	7.62	558	7.62	DE
12	7.62	7.62	7.62	287	7.62	DE
26	7.62	7.62	7.62	757	7.62	DE
52	7.62	7.62	7.62	527	7.62	DE
156	7.62	7.62	7.62	1914	7.62	DE
260	7.62	7.62	7.62	2974	7.62	DE

0RNK - Frequently Asked Questions (FAQ)

What is the current Inventiva share price?

The current share price of Inventiva is 7.62 €

How many Inventiva shares are in issue?

Inventiva has 52,116,000 shares in issue

What is the market cap of Inventiva?

The market capitalisation of Inventiva is EUR 397.12M

What is the 1 year trading range for Inventiva share price?

Inventiva has traded in the range of 7.62 € to 7.62 € during the past year

What is the PE ratio of Inventiva?

The price to earnings ratio of Inventiva is -1.1

What is the cash to sales ratio of Inventiva?

The cash to sales ratio of Inventiva is 5.24

What is the reporting currency for Inventiva?

Inventiva reports financial results in EUR

What is the latest annual turnover for Inventiva?

The latest annual turnover of Inventiva is EUR 23.16M

What is the latest annual profit for Inventiva?

The latest annual profit of Inventiva is EUR -110.43M

What is the registered address of Inventiva?

The registered address for Inventiva is 50 RUE DE DIJON, DAIX, 21121

What is the Inventiva website address?

The website address for Inventiva is www.inventivapharma.com

Which industry sector does Inventiva operate in?

Inventiva operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
GFINGfinity Plc	0.095p (72.73%)	576.77M
XSGXeros Technology Group Plc	0.70p (33.33%)	23.5M
OMIOrosur Mining Inc	9.55p (29.93%)	11.76M
SNGSynairgen Plc	2.49p (27.86%)	229.83k
IKAIlika Plc	34.25p (26.85%)	1.91M
WBIWoodbois Limited	0.0525p (-36.36%)	546.31M
CRVCraven House Capital Plc	US$ 0.275 (-26.67%)	49.99k
KRPZKropz Plc	0.85p (-26.09%)	432.89k
MACMarechale Capital Plc	2.35p (-24.19%)	26.92M
TRCThe Revel Collective Plc	0.175p (-22.22%)	5.52M
NTVONativo Resources Plc	0.0017p (0.00%)	2.07B
GFINGfinity Plc	0.095p (72.73%)	576.77M
WBIWoodbois Limited	0.0525p (-36.36%)	546.31M
OBDOxford Biodynamics Plc	0.55p (10.00%)	373.53M
MSMNMosman Oil And Gas Limited	0.04p (-8.05%)	338.97M